Tech Company Financing Transactions

Vital Therapies Funding Round

On 9/12/2007, Vital Therapies secured $28.1 million in investment from Versant Ventures, Delphi Ventures and HBM Healthcare Investments.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Medical Devices & Instruments

Mailing Address

15010 Ave. of Science 200
San Diego, CA 92128
USA

Phone

(858) 673-6840

Website

www.vitaltherapies.com

Email Address

[email protected]

Overview

Vital Therapies, Inc. (NASDAQ: VTL) is a new company formed in 2003 to continue the development of the ELAD (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient's liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Russell Cox

        

Chief Financial Officer

Michael Swanson

        

Chief Technical Officer

Robert Ashley

        

President

Duane Nash

        

Browse more venture capital transactions:

Prev: 9/12/2007: Tapioca Mobile venture capital transaction
Next: 9/12/2007: Wilson TurboPower venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary